Braveheart Bio, Inc.

XNAS

Last traded price · USD

$20.11

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $20.11
Volume: —
Day's high: —
Day's low: —

In brief

Braveheart Bio, Inc. is a US-listed company listed on Nasdaq, valued at about $1.81B.
Its shares closed at $20.11 on 4 Nov 2026.
From India you can buy BRVE in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Braveheart Bio, Inc. (BRVE) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole BRVE share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade BRVE options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

11.8 days to cover short interest
4.9M shares were sold short at the 15 Oct 2026 settlement; covering them would take 11.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average
The 4 Nov 2026 close of $20.11 was 13.0% below its 50-day average ($23.11).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Ahead of SPY over 1 month
1 month: +1.6% (SPY −1.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BRVE, SPY · as of 4 Nov 2026
Volume 1.7× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 655.5K shares was 1.7× the average of the 30 sessions before it (385.9K), as the price fell 6.0%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+1.6%

6 months—

1 year—

5 years—

Newswire

About

Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).

Website

Notable moves

September 25, 2026
−11.77%
September 21, 2026
−14.32%
September 8, 2026
+9.99%

Braveheart Bio, Inc.

XNAS

Last traded price · USD

$20.11

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $20.11
Volume: —
Day's high: —
Day's low: —

In brief

Braveheart Bio, Inc. is a US-listed company listed on Nasdaq, valued at about $1.81B.
Its shares closed at $20.11 on 4 Nov 2026.
From India you can buy BRVE in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Braveheart Bio, Inc. (BRVE) shares from India?

Do I need the price of a whole BRVE share to invest?

How much can I invest in US stocks in a year?

Can I trade BRVE options or futures?

Insights

Quotes run fifteen minutes behind.

11.8 days to cover short interest
4.9M shares were sold short at the 15 Oct 2026 settlement; covering them would take 11.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average
The 4 Nov 2026 close of $20.11 was 13.0% below its 50-day average ($23.11).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Ahead of SPY over 1 month
1 month: +1.6% (SPY −1.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BRVE, SPY · as of 4 Nov 2026
Volume 1.7× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 655.5K shares was 1.7× the average of the 30 sessions before it (385.9K), as the price fell 6.0%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+1.6%

6 months—

1 year—

5 years—

Newswire

About

Website

Notable moves

September 25, 2026
−11.77%
September 21, 2026
−14.32%
September 8, 2026
+9.99%

Braveheart Bio, Inc.

Braveheart Bio, Inc. in brief

11.8 days to cover short interest

Below its 50-day average

Ahead of SPY over 1 month

Volume 1.7× its 30-session average on 4 Nov 2026

Braveheart Bio, Inc.

Braveheart Bio, Inc. in brief

11.8 days to cover short interest

Below its 50-day average

Ahead of SPY over 1 month

Volume 1.7× its 30-session average on 4 Nov 2026